Ahead Together

We unite science, technology and talent to get ahead of disease together.

Scroll to explore

Ahead Together

Getting ahead of disease is one of the most inspiring challenges there is on the planet.

Explore how we will positively impact the health of 2.5 billion people over the next 10 years

global R&D centres
vaccines and medicines in development
in the Access to Medicine Index for people in low- to middle-income countries
turnover in 2022

Our leadership team

Find out more about our board and global leadership team who have overall responsibility for delivering our ambition, strategy and culture.

GlaxoSmithKline Pakistan Limited

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. In Pakistan, the Company has been providing trusted quality medicines, and vaccines to more than 200 million patients for over seven decades.

Our culture of being ambitious for patients, accountable for impact, and doing the right thing are the foundations for how, together, we’ll deliver for our patients and shareholders, making GSK a company where people can thrive. To achieve this, GSK has built an extensive manufacturing and distribution network, committed to growth and delivering a step change in performance.

GSK Pakistan caters to many therapy areas which include Anti-infectives, Dermatology, Analgesics, and Vaccines. We aim to consistently produce and improve access to quality medicines to make a positive impact on patients’ lives. Our key pharmaceutical brands include Augmentin, Velosef, Amoxil, Dermovate, Clobevate, Betnovate, and Calpol.

GSK holds the position of the largest multinational pharmaceutical company in Pakistan, based on volume, value, and the number of prescriptions generated*. Additionally, among the 700+* pharmaceutical companies operating in the country, both local and multinational, GSK ranks within the top 3 in terms of value and leads in volume. We employ around 1,700 people across our manufacturing, and commercial functions. Our Global Supply Chain (GSC) division, which manufactures over 430 million packs annually, consists of three facilities, all of which are situated in Karachi at F-268 SITE, West Wharf, and Korangi.

Policy positions

We have policies in place across GSK to ensure we meet the high standards we set ourselves as a company, and those that are expected of us externally.

Global Therapeutic areas